D 75N95020Q00153_JOFOC_Redacted.pdf
PDF 1 MB Posted
- Attached to
- Molecular Devices ImageXpress System Upgrade Federal contract opportunity
- Solicitation number
- 75N95020Q00153
About this file
This document summarizes a non-competitive combined synopsis and solicitation for the upgrade of a Molecular Devices ImageXpress System to enable optogenetic screening of neural response. The National Center for Advancing Translational Sciences at the National Institutes of Health seeks to purchase a high-performance 7 line laser light source, asynchronous dispense software, upgrade installation, and operational training from Molecular Devices or an authorized distributor. The upgrade is required to investigate neural response as part of efforts to seek treatments for opioid abuse. The determination to award without full and open competition is based on market research finding no other capable sources within the required timeframe. The contracting officer will determine price reasonableness before award.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| D 75N95020Q00153_NIH Invoice and Payment Provisions.pdf | ||
| D 75N95020Q00153_NIH Electronic Invoice Submission Instructions.pdf | ||
| D 75N95020Q00153_FAR 52.212-5.pdf | ||
| D 75N95020Q00153_FAR Provision 52.204-24.pdf | ||
| D 75N95020Q00153_CSS.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
RFQ No. 75N95020Q00153 develop three dimensional tissue models for more physiological relevant screening of treatments for disease conditions.
3. Description of the Supplies or Services Required to meet the agency’s needs (including the estimated value).
a. Project Title.
Acquisition of Molecular Devices ImageXpress System upgrade
b. Project Description.
The TBPL seeks to purchase one Molecular Devices ImageXpress System upgrade, which will enable performance of optogenetic screening of neural response to drugs and other stimulants. This will be used to seek out treatments for opioid abuse. The upgrade will be installed on instrumentation already on site at NCATS purchased in 2016 (via purchase order HHSN271201600036A).Installation of this upgrade is necessary and essential to investigate neural response.
The system upgrade is commercially available and is customized with options to fit the specific laboratory needs. The units required will include features and options as listed below:
1. One high-performance 7 line laser light source. Laser safe fluidics for IXMC including EC. UV/Vis Absorbance Spectra
2. Asynchronous dispense software that provides simultaneous dispense and imaging for IXM fluidic versions.
3. Upgrade installation
4. Operational training from a Molecular Devices qualified technician
Requirement Type.
Research & development (R&D) R & D support services Support services (non-R&D)
Supplies/equipment Information technology (IT) Construction Architect-engineer (A & E) services Design-build Other (specify): ____________________
Type of Action.
New requirement Follow-on
a. Name and address of the proposed contractor(s).
Molecular Devices 3860 North 1st street San Jose CA, 95134 https://www.moleculardevices.com/
This is a brand-name only requirement and will be competed among Molecular Devices and its authorized distributors.
b. Nature of the acquisition and proposed unique qualifications of the contractor(s).
The Molecular Devices ImageXpress System upgrade listed herein is available from only one source, and competition is precluded for the reasons indicated below. There are no substitutes available, as indicated by the market research attached.
Molecular Devices is the sole manufacturer of the ImageXpress System and is the sole vendor qualified to provide the necessary upgrades. The upgrades must be provided by the OEM to ensure the upgrades operate seamlessly with all aspects of the system and the system remains in precise working order. Molecular Devices has authorized distributors and this brand-name requirement will be competed among Molecular Devices and its authorized distributors.
The estimated cost of the required items is and is required to be delivered within 8 weeks after receipt of order.
6. Description of the efforts made to ensure that offers are solicited from as many potential sources as practicable. Indicate whether a FedBizOpps notice was or will be publicized as required by FAR Subpart 5.2 and, if not, which exception under FAR 5.202 applies.
The non-competitive combined synopsis / solicitation will be posted on SAM.gov for a reasonable amount of time in accordance with FAR Subpart 5.2 and all interested vendors will have an opportunity to respond.
7. Determination by the Contracting Officer that the anticipated cost/price to the Government will be fair and reasonable.
The Contracting Officer will make a price reasonableness determination before any award for this requirement is made.
File details come from the government source that posted it. Updated .